Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Characterization of Integrin Expression in a Well
article
OA: closed
CC0
AI-generated summary
This study characterized integrin expression in the Ishikawa endometrial cell line, a model for investigating human uterine receptivity and implantation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
THE HUMAN endometrium is a dynamically active tissue in the cycling reproductive-aged woman. As in other species (1), the human endometrium undergoes spatial and temporal changes that culminate in a defined period of uterine receptivity toward embryonic implantation (2). Although the mechanism for the establishment of receptivity remains poorly understood, the timing of the “window of implantation ” in the human appears to be confined to postovulatory days 6–10, based on morphological (3) studies and data from embryo transfers in hormonally prepared recipients in the in vitro fertilization setting (4). We have suggested that defects in uterine receptivity may account for a significant proportion of failed in vitro fertilization attempts (5) as well as the underlying cause in many couples with unexplained infertility (6), endometriosis (7), and luteal phase defect (8), supported by an increasing amount of clinical data (9). Few good models currently exist, however, to study the role of specific endometrial proteins in human implantation. Although numerous endometrial cancer cell lines have been established and characterized, the Ishikawa cell line
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-10T10:42:51.436959+00:00
License: CC0
· commercial use OK